NCT00567203View on ClinicalTrials.gov

A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Schizophrenia

Interventions

DRUG

PF-3463275

PF-3463275 10mg

DRUG

PF-3463275

PF-3463275 25mg

DRUG

Placebo

Placebo

Trial Locations (2)

91206

Pfizer Investigational Site, Glendale

08046

Pfizer Investigational Site, Willingboro

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY